Maternal Aspects of Preeclampsia

Abstract

Preeclampsia is almost exclusively a disorder of human pregnancy, the pathogenesis of which remains unknown. Pre-eclampsia affects 3 to 8% of all pregnancies and still remains a leading cause of maternal morbidity and mortality. Because of the defective uteroplacental unit associated with preeclampsia adverse fetal, neonatal events usually observed in these cases. As well as fetal, neonatal adverse effects, equally important are the adverse effects on the maternal hematologic, cardiovascular and pulmonary, neurologic, renal, and gastrointestinal system. The aim of this review is to underline the maternal adverse effects of preeclampsia.

Keywords

• preeclampsia,HELLP syndrome,hypertension,pregnancy complications

Preeklempsinin Maternal Sonuçları

Abstract

Preeklampsia yalnızca insan gebeliğinde görülen bir hastalıktır, patogenezi bilinmemektedir. Tüm gebeliklerin % 3 ile 8 ini etkilemektedir ve hala maternalmorbidite ve mortalitenin en sık nedenidir. Preklampside bozulmuş uteroplasental üniteye bağlı olarak, bu olgularda fetal ve neonatal kötü sonuçlar görülebilmektedir. Fetal ve neonatal kötü sonuçların yanında, annede de hematolojik, kardiyovasküler, pulmoner, nörolojik, renal ve gastrointestinal sistemde anlamlı ölçüde kötü sonuçlar görülebilmektedir. Bu derlemede preeklampsiye bağlı oluşan kötü maternal sonuçların değerlendirilmesi amaçlanmıştır.

Keywords

• Preeklempsi,HELLP sendromu,hipertansiyon,gebelik komplikasyonları

References

1. 1. World Health Organisation: Maternal Mortality in 2000; Estimates Developed by WHO, UNICEF and UNFPA. Geneva, World Health Organisation, 2004.
2. 2. Borghi C, Esposti DD, Immordino V, et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol. 2000; 183:140-147.
3. 3. Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol. 1972; 112:440-450.
4. 4. Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol. 1985; 151:958- 966.
5. 5. Cotton DB, Lee W, Huhta JC, et al. Hemodynamic profile of severe pregnancy-induced hypertension. Am J Obstet Gynecol. 1988; 158:523-529.
6. 6. Oian P, Maltau JM, Noddeland H, et al. Transcapillary fluid balance in pre-eclampsia. Br J Obstet Gynaecol. 1986; 93: 235-239.
7. 7. Sibai BM, Mabie BC, Harvey CJ, et al. Pulmonary edema in severe preeclampsia-eclampsia: Analysis of thirty-seven consecutive cases. Am J Obstet Gynecol. 1987;156:1174-1179.
8. 8. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: A population-based study. J Reprod Med. 2007; 52: 1046-1051.

9. 9. Mabie WC, Hackman BB, Sibai BM. Pulmonary edema associated with pregnancy: Echocardiographic insights and implications for treatment. Obstet Gynecol. 1993; 81: 227-234.
10. 10. Männistö T, Mendola P, Vääräsmäki M, Järvelin MR, Hartikainen AL, Pouta A, Suvanto E. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681- 9011.
11. 11. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000; 342:1334-1349.
12. 12. Catanzarite V, Willms D, Wong D, et al. Acute respiratory distress syndrome in pregnancy and the puerperium: Causes, courses, and outcomes. Obstet Gynecol. 2001; 97:760-764.
13. 13. Catanzarite VA, Willms D. Adult respiratory distress syndrome in pregnancy: Report of three cases and review of the literature. Obstet Gynecol Surv. 1997; 52: 381-392.
14. 14. Deblieux PM, Summer WR. Acute respiratory failure in pregnancy. Clin Obstet Gynecol. 1996; 39: 143-152.
15. 15. Alvarez NR, Marin R, Testa A, et al: Preeclampsia and peripartum cardiomyopathy: Infrequent association. Nefrologia. 2001; 21:84- 87
16. 16. Pearson GD, Veille JC, Rahimtoola S, et al: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (NIH) workshop recommendations and review. J Am Med Assoc. 2000; 283:1183-1188.
17. 17. Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005; 33:S340-S346.
18. 18. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001; 344: 1567-1571.
19. 19. Habli M, O’Brien T, Nowack E, et al. Peripartum cardiomyopathy: Prognostic factors for long-term maternal outcome. Am J Obstet Gyencol. 2008; 199: e1-e5.
20. 20. Hartel D, Sorges E, Carlsson J, et al. Myocardial infarction and thromboembolism during pregnancy [in German]. Herz. 2003; 28: 175-184.
21. 21. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: Evidence from the Royal College of General Practitioners’ oral contraception study. BMJ. 1989; 298:165-168.
22. 22. Jonsdottir LS, Arngrimsson R, Geirsson RT, et al: Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995; 74: 772-776.
23. 23. Fleming SM, O’Gorman T, Finn J, et al. Cardiac troponin I in preeclampsia and gestational hypertension. Br J Obstet Gynaecol. 2000; 107:1417-1420.
24. 24. Haukkamaa L, Salminen M, Laivuori H, et al: Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol. 2004; 93:805-808.
25. 25. Wikstrom AK, Haglund B, Olovsson M, et al. The risk of maternal ischaemic heart disease after gestational hypertensive disease. Br J Obstet Gynaecol. 2005; 112:1486-1491.
26. 26. Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and metal-analysis. BMJ. 2007; 335:974.
27. 27. Gaugler-Senden IP, Berends AL, de Groot CJ, et al. Severe, very early onset preeclampsia: Subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol. 2008; 140:171-177.
28. 28. Okanloma KA, Moodley J. Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet. 1989; 71: 223- 225.
29. 29. Zwart JJ, Richters A, Ory F, et al. Eclampsia in the Netherlands. Obstet Gynecol. 2008; 112: 820-827.
30. 30. Knight M. Eclampsia in the United Kingdom 2005. Br J Obstet Gynaecol. 2007; 114:1072-1078.
31. 31. Ito I, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol. 1995; 16: 1344- 1346.
32. 32. Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia. Clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000; 217:371-376.
33. 33. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996; 334:494- 500.
34. 34. Paulson OB. Blood– brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol. 2002; 12:95-501.
35. 35. Veltkamp R, Kupsch A, Polasek J, et al. Late onset postpartum eclampsia without preeclamptic prodromi. Clinical and neuroradiological presentationin two patients. J Neurol Neurosurg Psychiatry. 2000; 69:824-827.
36. 36. Belfort MA, Giannina G, Herd JA. Transcranial and orbital Doppler ultrasound in normal pregnancy and preeclampsia. Clin Obstet Gynecol. 1999; 42: 479-506.
37. 37. Zeeman GG, Hatab MR, Twickler DM. Increased cerebral blood flow in preeclampsia with magnetic resonance imaging. Am J Obstet Gynecol. 2004; 191:1425-1429.
38. 38. Brown CE, Purdy P, Cunningham FG. Head computed tomographic scans in women with eclampsia. Am J Obstet Gynecol. 1988; 159: 915-920.
39. 39. Cunningham FG, Twickler DM. Cerebral edema complicating eclampsia. Am J Obstet Gynecol. 2000; 182: 94-100.
40. 40. Zeeman GG, Fleckenstein JL, Twickler DM, et al. Cerebral infarction in eclampsia. Am J Obstet Gynecol. 2004; 190:714-720.
41. 41. Loureiro R, Leite CC, Kahhale S, et al. Diffusion imaging may predictreversible brain lesions in eclampsia and severe preeclampsia. Initial experience. Am J Obstet Gynecol. 2003; 189: 1350-1355.
42. 42. Imaizumi T, Horita Y, Chiba M, et al. Dot-like hemosiderin spots on gradient echo T2-weighted MRI are associated with intracranial hemorrhage. J Neuroimaging. 2004; 14:251-257.
43. 43. Drislane FW, Wang AM. Multifocal cerebral hemorrhage in eclampsia and severe preeclampsia. J Neurol. 1997; 244:194-198.
44. 44. Witlin AG, Friedman SA, Egerman RS, et al. Cerebrovascular disorders complicating pregnancy—Beyond eclampsia. Am J Obstet Gynecol. 1997; 176:1139-1148.
45. 45. Weiner CP. The clinical spectrum of preeclampsia. Am J Kidney Dis. 1987; 9:312-316.
46. 46. Moseman CP, Shelton S. Permanent blindness as a complication of pregnancy induced hypertension. Obstet Gynecol. 2002; 100:943-945.
47. 47. Cunningham FG, Fernandez CO, Hernandez C. Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol. 1995; 172:1291-1298.
48. 48. Fei X, Hongxiang Z, Qi C, Daozhen C. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia. Adv Clin Exp Med. 2012; 21: 573-9.
49. 49. Sibai BM, Eclampsia VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol. 1990; 163:1049-1054.
50. 50. Magee LA, von Dadelszen P. The management of severe hypertension. Semin Perinatol. 2009; 33:138-42.
51. 51. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia. Lessons learned from recent trials. Am J Obstet Gynecol. 2004; 190:1520-1526.
52. 52. Sibai BM. Diagnosis, prevention and management of eclampsia. Obstet Gynecol. 2005; 105:402-410.
53. 53. Konstantinopoulos PA, Mousa S, Khairallah R, et al. Postpartum cerebral angiopathy. An important diagnostic consideration in the postpartumperiod. Am J Obstet Gynecol. 2004; 191:375-377.
54. 54. Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years after eclampsia. Am J Obstet Gynecol. 2009; 200:504 e1-5.
55. 55. Aukes AM, Wessel I, Dubois AM, et al. Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol. 2007. 197: 365. e1-.e6.
56. 56. Brussé I, Duvekot J, Jongerling J, et al. Impaired maternal cognitive functioning after pregnancies complicated by severe pre-eclampsia. A pilot case-control study. Acta Obstet Gynecol Scand. 2008; 87: 408-412.
57. 57. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006; 46.794-803.
58. 58. Lawn N, Laich E, Ho S, et al. Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy. Accident or association? Neurology. 2004; 62: 1352-1356.
59. 59. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life. Results from cohort study. Br Med J. 2003; 326: 845.
60. 60. Christensen T, Klebe JG, Bertelsen V, et al. Changes in renal volume during normal pregnancy. Acta Obstet Gynecol Scand 68.541, 1989.
61. 61. Rasmussen PE, Nielse FH. Hydronephrosis during pregnancy: A literature survey. Eur J Obstet Gynecol Reprod Biol. 1988; 27:249- 259.
62. 62. Davison JM, Dunlop W. Renal haemodynamics and tubular function in normal human pregnancy. Kidney Int. 1980; 18:152-161.
63. 63. Karumanchi SA, Maynard SE, Stillman IE, et al. Preeclampsia. A renal perspective. Kidney Int. 2005; 67:2101-2113.
64. 64. Spargo Bh, Lichtig C, Luger AM, et al. The renal lesion in preeclampsia. Perspect Nephrol Hypertens. 1976; 5:129-137.
65. 65. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007; 18:2281-2284.
66. 66. Moran P, Baylis PH, Lindheimer MD, et al. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol. 2003; 14:648-652.
67. 67. Naqvi R, Akhtar F, Ahmed E, et al. Acute renal failure of obstetrical origin during 1994 at one center. Ren Fail. 1996; 18:681-683.
68. 68. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol. 1990; 162: 777-783.
69. 69. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J ObstetGynecol. 1993; 168: 1682-1687.
70. 70. Dildy GA, Belfort MA, Saade GR, et al. Critical Care Obstetrics (ed. 4). 2004. Malden, MA, Blackwell Science.
71. 71. Shammas AG, Maayah JF. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J. 2000; 21:190- 192.
72. 72. Suzuki H, Watanabe Y, Arima H, et al. Short- and long-term prognosisof blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol. 2008; 12:102-109.
73. 73. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996; 335:226- 232.
74. 74. Nossent HC, Swaak TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol. 1990; 17:771-776.
75. 75. Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemiclupus erythematosus. Am J Obstet Gynecol. 2005; 192:1897-1904.
76. 76. Repke JT. Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus. J Reprod Med. 1998; 43:350-354.
77. 77. Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int. 1985; 27:74-79.
78. 78. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count. A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982; 142:159-167.
79. 79. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004; 103:981-991.
80. 80. Martin JN Jr, Rinehart BK, May WL, et al: The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999; 180:1373-1384.
81. 81. Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol. 2011; 205:191- 8.
82. 82. Sibai BM, Taslimi MM, El-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and lowplatelets in severe preeclampsia-eclampsia. AmJ Obstet Gynecol. 1986; 155:501-509.
83. 83. Sullivan CA, Magann EF, Perry KG Jr, et al. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol. 1994; 171:940-943.
84. 84. Barton JR, Riely CA, Adamec TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome(hemolysis, elevated liver enzymes, and low platelet count).Am J Obstet Gynecol. 1992; 167:1538-1543.
85. 85. Visser W, Wallenburg HCS. Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol. 1995; 102:111-117.
86. 86. van Pampus MG, Wolf H, Westenberg SM, et al. Maternal and perinataloutcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 1998; 76:31-36.
87. 87. van Runnard Heimel PJ, Huisjes AJM, Fraux A, et al. A randomized placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet GynecolReprod Biol. 2006; 128:187-193.
88. 88. Fonseca JE, Mendez F, Catano C, et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome. A doubleblind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005; 193:1591-1598.
89. 89. Katz L, deAmorim MM, Figueiroa JN, et al. Postpartum dexamethasonefor women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. A double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2008; 198: e1-e8.
90. 90. Ilbery M, Jones AR, Sampson J. Lupus anticoagulant and HELLP syndrome complicated by placental abruption, hepatic, dermal andadrenal infarction. Aust NZ J Obstet Gynaecol. 1995; 35:215-
91. 91. Alsulyman O, Castro MA, Zuckerman E, et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol. 1996; 88:644-646.
92. 92. Wicke C, Pereira PL, Neeser E, et al. Subcapsular liver hematoma in HELLP syndrome. Evaluation of diagnostic and therapeutic options-aunicenter study. Am J Obstet Gynecol. 2004; 190:106-112.
93. 93. Goodlin RC, Anderson JC, Hodgson PE. Conservative treatment of liver hematoma in the postpartum period: A report of two cases. J Reprod Med. 1985; 30:368.
94. 94. Smith JG Jr, Moise KJ Jr, DildyGAIII, et al. Spontaneous rupture of the liver during pregnancy. Current therapy. Obstet Gynecol. 1991; 77:171-175.
95. 95. Reck T, Bussenius-Kammerer M, Ott R, et al. Surgical treatment of HELLP syndrome-associated liver rupture—An update. Eur J Obstet Gynecol Reprod Biol. 2001; 99:57-65.
96. 96. Hunter S, Martin M, Benda JA, et al. Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol. 1995; 85: 819-822.
97. 97. Wust MD, Bolte AC, de Vries JI, et al. Pregnancy outcome after previous pregnancy complicated by hepatic rupture. Hypertens Pregnancy. 2004; 23:29-35.
98. 98. Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol. 2003; 188:1504-7.
99. 99. Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets).Subsequent pregnancy outcome and long-term prognosis. Am JObstet Gynecol. 1995; 172:125-129.
100. 100. Eddy JJ, Gideosen MD, Song JY, et al. Pancreatitis in pregnancy. Obstet Gynecol. 2008; 112:1075-1081.
101. 101. Ramin KD, Ramin SM, Richey SD, et al. Acute pancreatitis in pregnancy. Am J Obstet Gynecol. 1995; 173:187-191.
102. 102. Hojo S, Tsukimori K, Hanaoka M, et al. Acute pancreatitis and cholecystitis associated with postpartum HELLP syndrome. A case and review. Hypertens Pregnancy. 2007; 26:23-29.